You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / ALBERT DAVID

ALBERT DAVID
Intrinsic Value | Fundamental Analysis

Returns | 1W : 14.8% , 1M : 19.6%,1Y : 9.9%
BOM : 524075     NSE : ALBERTDAVD    
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Upward
Pledged Shares : None or < 25%
Apr 22,2021
Price(EOD): Rs. 465.10
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
MarketCap: Rs. 265.11 Cr
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
ALBERT DAVID 14.8% 19.6% 9.9%
SUN PHARMACEUTICAL INDUSTRIES 1.2% 11.4% 36.3%
DR REDDYS LABORATORIES 7.4% 23.5% 34.1%
DIVIS LABORATORIES -0.8% 14.8% 61.7%
CIPLA 3.3% 25.1% 62.3%
BIOCON -1.2% 2.6% 12.1%
AUROBINDO PHARMA 8.6% 23.1% 82.7%
LUPIN 1.1% 6.1% 34.7%
TORRENT PHARMACEUTICALS 0.4% 8.8% 11.6%

FUNDAMENTAL ANALYSIS OF ALBERT DAVID

 
Fundamentals Score
[Last Annual Data : Mar2020 | TTM
Trailing Twelve Months (TTM) is calculated using last 4 quarterly data and is a good substitute to track Annual results.
Learn More
]
Show Me the Stocks with Fundamentals better than ALBERT DAVID Premium


VALUATION OF ALBERT DAVID

 
Valuation Score
RatioValue
P/E
P/B
P/S
13.85
P/E Calculated based on EPS of 33.59
[ Mar2020 - Standalone Results ]

1.19
P/B Calculated based on Book Value of 390.38
[ Mar2020 - Standalone Results ]

0.94
P/S Calculated based on Revenues of 282.905 Cr
[ TTM - Standalone Results ]

Show Me the Stocks with Valuation better than ALBERT DAVID Premium


FAIR VALUE OF ALBERT DAVID

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
100%
35%
51%

SHARE PRICE MOMENTUM OF ALBERT DAVID

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
0.01
0
0.15
0.05
-
-
-
-
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares
0 %
As on : Sep2020

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Standalone 1 Qtr Growth 4 Qtr Growth
Revenue
Op Profit
EBIDT
Net Income
-8.92%
-25.62%
-30.67%
-37.51%
-17.93%
9.61%
9.96%
16.55%
QtrlyTrend
-2
Latest Qtr: Dec2020

ALBERT DAVID related INDICES

BSE Indices1W1M1Y
S&P BSE HEALTHCARE 3.7% 15.3% 56.9%
S&P BSE SMALL CAP 0.5% 2.5% 90.8%
S&P BSE MIDSMALLCAP 0.2% 1.7% 80%
S&P BSE ALLCAP -0.8% -0.3% 59.7%
No NSE index found

FAQ [Frequently Asked Questions]


Is ALBERTDAVD good for long term investment?

As on 22-Apr-2021, the Fundamentals of ALBERTDAVD are Poor and hence it's not good for long term investment ! See Financial Performance of ALBERT DAVID . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is ALBERTDAVD UnderValued or OverValued?

As on 22-Apr-2021, ALBERTDAVD is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of ALBERTDAVD ?

As on 22-Apr-2021, the Intrinsic Value of ALBERTDAVD is Rs. 307.72 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 233.05
Fair Value [Median EV / Sales Model] : Rs. 344.41
Fair Value [Median Price / Sales Model] : Rs. 307.72
Median Fair Value of ALBERTDAVD : Rs. 307.72

Is ALBERTDAVD trading at a Premium or Discount?

As on 22-Apr-2021, ALBERTDAVD is trading at a Premium of 51% based on the Median Intrinsic Value!

Is it right time to buy ALBERTDAVD shares?

As on 22-Apr-2021, ALBERTDAVD is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!

What is the Financial Performance of Industry Peers of ALBERTDAVD?

Check out Financials of Industry Peers using below links:
Financials of SUN PHARMACEUTICAL INDUSTRIES LTD
Financials of DR REDDYS LABORATORIES LTD
Financials of DIVIS LABORATORIES LTD
Financials of CIPLA LTD
Financials of BIOCON LTD
Financials of AUROBINDO PHARMA LTD
Financials of LUPIN LTD
Financials of TORRENT PHARMACEUTICALS LTD
Financials of CADILA HEALTHCARE LTD
Financials of ABBOTT INDIA LTD

What are the Frequent Comparisons with ALBERTDAVD?

ALBERT DAVID LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DR REDDYS LABORATORIES LTD
ALBERT DAVID LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD
ALBERT DAVID LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD
ALBERT DAVID LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs BIOCON LTD
ALBERT DAVID LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs AUROBINDO PHARMA LTD
ALBERT DAVID LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs LUPIN LTD
ALBERT DAVID LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs TORRENT PHARMACEUTICALS LTD
ALBERT DAVID LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CADILA HEALTHCARE LTD
ALBERT DAVID LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs ABBOTT INDIA LTD

Open Demat Account & Start Investing
    Affiliate Links

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z